BPC-157 is one of the most-studied research peptides in soft-tissue and connective-tissue research. It originated as a 15-amino-acid fragment isolated from a larger protein found in gastric juice — Body Protection Compound — and has since become a reference compound in preclinical wound-healing, tendon, ligament, and gastrointestinal studies.
This piece is a research-oriented overview: what BPC-157 is, what areas it has been used to study, how it compares to TB-500, and how to evaluate the supply you’re buying. As always, the content is intended for laboratory researchers — these compounds are not therapeutic agents.
The Origin of BPC-157
BPC-157 is a synthetic pentadecapeptide derived from a larger gastroprotective protein originally characterized in the early 1990s. The full sequence has been studied in preclinical contexts ranging from gastric ulcer healing to musculoskeletal repair. The peptide is stable in solution under typical storage conditions and is widely used in animal-model research.
The molecule’s relative stability and broad activity profile have made it a workhorse compound in tissue-repair studies — used in dozens of published rodent investigations across recovery, inflammation, and vascular biology.
Research Areas Where BPC-157 Has Been Used
Preclinical literature has investigated BPC-157 in several distinct contexts. The following are areas of research interest — not clinical claims.
Tendon and ligament models
Rodent studies have explored its role in tendon-to-bone healing, achilles transection models, and ligament injury repair, often comparing histological and tensile-strength outcomes against vehicle controls.
Gastrointestinal protection models
Given its protein-of-origin, BPC-157 has been studied in models of gastric ulcer formation, NSAID-induced injury, and inflammatory bowel models.
Vascular and microvascular research
Several papers describe effects on angiogenesis-related markers and endothelial behavior in cell-culture and animal-model work.
Muscle injury models
Crush-injury and exercise-induced damage models in rodents have used BPC-157 to study recovery markers and histology over defined time courses.
BPC-157 vs TB-500 — Mechanistic Differences
The two peptides are often grouped under “recovery research” but they are mechanistically distinct.
BPC-157: 15-amino-acid fragment of body protection compound (gastric juice protein). Primary research focus: connective tissue, GI, vascular. Often used standalone or paired with TB-500.
TB-500: 17 amino acid fragment of thymosin beta-4. Primary research focus: actin binding, cell migration, wound closure. Often used standalone or paired with BPC-157.
Because the two operate on different molecular pathways, researchers sometimes use a combined preparation. We offer a pre-mixed BPC-157 + TB-500 blend for studies that compare the combination against single-peptide arms.
Adjacent Recovery Research Compounds
For broader connective-tissue and skin research panels, several other peptides appear regularly alongside BPC-157:
- GHK-Cu — copper-binding tripeptide, widely studied in skin, hair, and extracellular-matrix research.
- KPV — anti-inflammatory tripeptide derived from α-MSH; studied in mucosal and skin inflammation models.
These three compounds, alongside BPC-157 and TB-500, form a fairly standard “tissue research” peptide set for laboratories building repair and inflammation studies.
Quality Notes Specific to BPC-157
Because BPC-157 is widely sold across hundreds of online vendors, batch-level purity varies dramatically. In comparative testing across the supply landscape, batches range from below 90% to above 99% by HPLC.
Specific things to verify for any BPC-157 supply:
- ≥99% HPLC purity on the batch you receive
- Mass spec confirmation (the expected molecular mass for the standard 15-residue sequence)
- Lot number on the vial matching the COA
- Visible lyophilized cake (not collapsed or melted)
Every BPC-157 batch in our line is tested by Janoshik Analytical with the report attached to the product page. Browse all our published reports on the Certificates of Analysis page.
Reconstitution and Handling Basics
BPC-157 ships as a lyophilized powder. Standard preparation involves reconstituting with bacteriostatic or sterile water to a working concentration appropriate to the study design. We carry Hospira bacteriostatic water for multi-dose reconstitution protocols. Always follow the protocol your study or institution requires.
Frequently Asked Questions
How is BPC-157 different from the parent protein?
It is a 15-amino-acid fragment that captures the activity-relevant region of the larger gastric protein. The fragment is shorter, easier to synthesize, and more practical for laboratory use.
Is BPC-157 stable in solution?
Reconstituted BPC-157 is considered relatively stable under refrigerated conditions for working windows commonly cited in published methods. As with any peptide, integrity should be confirmed for studies requiring long shelf life.
Why do researchers combine BPC-157 with TB-500?
The two act on different molecular pathways. Combining them in studies allows comparison of single-pathway versus multi-pathway research approaches to recovery and repair.
For Research Use Only. Not for Human Consumption. The products and references on this page are intended exclusively for in vitro and animal-model laboratory research. They are not FDA-approved drugs and are not therapeutic agents.